Duality Biologics

Duality Biologics is a clinical-stage biotechnology company dedicated to developing the next generation of antibody-drug conjugates (ADCs) for the treatment of cancer and autoimmune diseases. The company has built a robust pipeline of over 10 best-in-class and first-in-class ADC programs, leveraging its proprietary technology platforms: DITAC (Duality Immune Toxin Antibody Conjugate) and DIMAC (Duality Immune Modulating Antibody Conjugate). These platforms are designed to produce ADCs with superior safety profiles, improved therapeutic windows, and enhanced efficacy compared to traditional ADCs.

Founded in January 2020 by Dr. John Zhu, a seasoned company builder in the healthcare industry, Duality Biologics is led by an experienced management team with a proven track record in discovering and developing novel medicines. The company is headquartered in Shanghai, China and operates in both China and the United States. Duality Biologics has secured over $120 million in funding and has made significant progress in its development, with several drug candidates entering clinical trials. Their commitment to innovation and collaboration has resulted in strategic partnerships with companies like Harbour BioMed and Adcendo, further strengthening their global reach and accelerating their pipeline development.

Duality Biologics is a clinical-stage biotech company committed to developing novel antibody-drug conjugates (ADCs) to treat cancer and autoimmune diseases. They leverage their proprietary DITAC and DIMAC platforms to create next-generation ADCs with improved therapeutic windows and safety profiles, aiming to translate innovative modalities into reality and address unmet medical needs worldwide.

Duality Biologics fosters a culture that values collaboration, innovation, and excellence. The company emphasizes open communication and teamwork, creating an environment where employees feel empowered to contribute their unique perspectives and drive the development of groundbreaking therapies. Duality Biologics promotes a sense of ownership and accountability, encouraging its employees to take pride in their work and contribute to the company's success.